v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | NCT04527562 |
Full text link
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
|
First author
Last imported at : Jan. 13, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
|
Contact
Last imported at : Jan. 13, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
rahmanmotlabur@gmail.com |
Registration date
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
2020-08-26 |
Recruitment status
Last imported at : Jan. 13, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Completed |
Study design
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
RCT |
Allocation
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Randomized |
Design
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Parallel |
Masking
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Blind label |
Center
Last imported at : March 15, 2023, 4 a.m. Source : ClinicalTrials.gov |
single-center |
Study aim
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Treatment |
Inclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m. Source : ClinicalTrials.gov |
inclusion criteria: males and females of least 18 years of age and can swallow tablets competent and willing to provide informed consent patient must have received a diagnosis of covid-19 infection with positive rt-pcr for sars cov-2 within the last 3 days patients with moderate symptoms (according to national guidelines on clinical management of coronavirus disease 2019 (covid- 19).version 7.0 .2020, dghs, mohfw, government of the people's republic of bangladesh). following features of moderate covid-19 must be present- fever or history of fever cough and /or shortness of breath oxygen saturation 94% or more pneumonia -pulmonary consolidations on chest imaging (chest x ray or ct scan of chest) involving less than 50%of lungs crb 65 score 0 |
Exclusion criteria
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
- pregnancy and breast-feeding - known hypersensitivity to colchicine - known chronic illness e.g hepatic failure, chronic kidney disease (egfr<30ml/min), decompensated heart failure, long qt syndrome (qtc >450 msec.) - patient with inflammatory bowel disease (crohn's disease or ulcerative colitis), chronic diarrhea or malabsorption - patient currently taking colchicine for other indications (mainly chronic indications represented by familial mediterranean fever or gout) - patient undergoing chemotherapy for cancer - patient is considered by the investigator, for any reason, to be an unsuitable candidate for the study. |
Number of arms
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
2 |
Funding
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Dhaka Medical College |
Inclusion age min
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
18 |
Inclusion age max
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
100 |
Countries
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Bangladesh |
Type of patients
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Moderate disease at enrollment |
Severity scale
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
3: Moderate disease at enrollment |
Total sample size
Last imported at : Jan. 13, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
299 |
primary outcome
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Time to develop clinical deterioration, defined as the time from randomization to a deterioration of two points (from the status at randomization) on a Seven-category ordinal scale. |
Notes
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
None |
Phase
Last imported at : Nov. 16, 2021, 6:30 p.m. Source : ClinicalTrials.gov |
Not reported |
Arms
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
[{"arm_notes": "", "treatment_id": 310, "treatment_name": "Colchicine", "treatment_type": "Metabolic agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}] |